Offer - Urjas Oil for just ₹ 1 X
Agloscrab is a commercial drug that is prescribed in the form of Emulsion. It is typically used for the treatment of Scabies, Head Lice. Secondary and off-label uses of Agloscrab have also been mentioned below.
The right dosage of Agloscrab depends on the age, gender, and medical history of the patient. The condition it has been prescribed for, and the route of administration also determine the right dosage. Detailed information has been provided in the dosage section.
Some other side effects of Agloscrab have been listed ahead. Such side effects of Agloscrab normally do not last long and go away once the treatment is completed. If, however, they worsen or do not go away, please speak with your physician.
In addition, Agloscrab's effect is Severe during pregnancy and Moderate for lactating mothers. It is important to know if Agloscrab has any effect on the kidney, liver and heart. Information on such adverse effects, if any, has been given in the Agloscrab related warnings section.
Agloscrab is not recommended if you suffer from certain medical conditions as it can have adverse effects. Epilepsy are examples of such conditions. The section on Agloscrab contraindications lists all such conditions.
Drug interactions for Agloscrab have been reported in the medical literature. A complete list of these interactions is given below.
In addition to the above precautions for Agloscrab, it is important to know that it is safe while driving, and is habit-forming.
Agloscrab is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Is the use of Agloscrab safe for pregnant women?
Agloscrab should not be taken during pregnancy, or should only be taken on the advice of a doctor as it may have severe side effects.
Is the use of Agloscrab safe during breastfeeding?
Agloscrab may lead to some side effects in breastfeeding women. If you witness any unusal symptoms after taking Agloscrab, discontinue its use and call your doctor right away. Follow your doctor's advice regarding the use of Agloscrab.
What is the effect of Agloscrab on the Kidneys?
Agloscrab rarely affects the kidneys.
What is the effect of Agloscrab on the Liver?
You may experience side effects on your liver after taking Agloscrab. If this happens, then discontinue its use. Consult your medical practitioner, do as he/she suggests.
What is the effect of Agloscrab on the Heart?
Agloscrab has very mild side effects on the heart.
Agloscrab should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
If you are suffering from any of the following diseases, you should not take Agloscrab unless your doctor advises you to do so -
Is this Agloscrab habit forming or addictive?
Agloscrab is not addictive in nature.
Interaction between Food and Agloscrab
Due to a lack of research, nothing can be said about the consequences of taking Agloscrab together with food.
Interaction between Alcohol and Agloscrab
No research has been done on this till date. Therefore, it is not known what the effect of taking Agloscrab with alcohol will be.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 900
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Lindane (LIHN-dane) Lotion
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Lindane Shampoo
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 903
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 777-778